WHOLE EXOME BY NGS SEQUENCING(RESEARCH PANEL)
MRP - ₹ 42,750
What is a WHOLE EXOME BY NGS SEQUENCING(RESEARCH PANEL)?
The Whole Exome by NGS Sequencing (Research Panel) test is an advanced genetic analysis that examines the protein-coding regions of genes, known as the exome, using next-generation sequencing technology. Since most disease-causing genetic variations are found within these regions, the test helps identify potential genetic changes associated with inherited disorders, rare diseases, and unexplained medical conditions. Its purpose is to support detailed genetic research, aid diagnosis, and guide further clinical evaluation and personalized healthcare decisions.
Additional Information
| Also known as/ Other names: | Whole Exome Sequencing (WES), NGS Whole Exome Analysis, Research Whole Exome Panel, Comprehensive Exome Sequencing Test |
| Parameters: | 1 |
| Recommended for: | M/F/Others |
| Sample Type: | Blood |
| Patient Preparation: | Minimum gap from Chemotherapy should be 2 weeks |
| Reports: | 4-6 weeks |
FAQs
No, some genetic changes may remain undetectable, especially outside protein-coding regions or due to current scientific limitations.
Whole exome sequencing analyzes protein-coding gene regions, while whole genome sequencing examines nearly the entire genetic material.
Most known disease-causing mutations occur within protein-coding regions, making exome analysis highly valuable for identifying clinically relevant genetic variations.
Yes, whole exome sequencing is particularly useful for investigating rare, complex, or previously undiagnosed inherited medical conditions.
Certainly, whole exome sequencing may identify genetic variations missed by targeted or limited genetic testing methods.
Yes, the test may identify inherited genetic variations and help evaluate inheritance patterns through family-based analysis.
Certainly, ongoing research may help identify newly recognized disease-associated genetic variations through advanced exome data analysis.
